HK1117548A1 - Ob-fold used as scaffold for engineering new specific binders - Google Patents

Ob-fold used as scaffold for engineering new specific binders

Info

Publication number
HK1117548A1
HK1117548A1 HK08111475.3A HK08111475A HK1117548A1 HK 1117548 A1 HK1117548 A1 HK 1117548A1 HK 08111475 A HK08111475 A HK 08111475A HK 1117548 A1 HK1117548 A1 HK 1117548A1
Authority
HK
Hong Kong
Prior art keywords
scaffold
new specific
specific binders
engineering new
fold used
Prior art date
Application number
HK08111475.3A
Other languages
English (en)
Inventor
Frederic Pecorari
Pedro Alzari
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Centre Nat Rech Scient filed Critical Pasteur Institut
Publication of HK1117548A1 publication Critical patent/HK1117548A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1041—Ribosome/Polysome display, e.g. SPERT, ARM
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/20—Antigen-binding scaffold molecules wherein the scaffold is not an immunoglobulin variable region or antibody mimetics
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polyurethanes Or Polyureas (AREA)
HK08111475.3A 2006-12-04 2008-10-16 Ob-fold used as scaffold for engineering new specific binders HK1117548A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06291869A EP1930342B1 (de) 2006-12-04 2006-12-04 Als Gerüst verwendeter OB-Fold zur Entwicklung neuer spezifischer Bindemittel

Publications (1)

Publication Number Publication Date
HK1117548A1 true HK1117548A1 (en) 2009-01-16

Family

ID=37964126

Family Applications (2)

Application Number Title Priority Date Filing Date
HK08111475.3A HK1117548A1 (en) 2006-12-04 2008-10-16 Ob-fold used as scaffold for engineering new specific binders
HK10107761.0A HK1141304A1 (en) 2006-12-04 2010-08-13 Ob-fold used as scaffold for engineering new specific binders ob-fold

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK10107761.0A HK1141304A1 (en) 2006-12-04 2010-08-13 Ob-fold used as scaffold for engineering new specific binders ob-fold

Country Status (13)

Country Link
US (4) US20100145008A1 (de)
EP (3) EP1930342B1 (de)
JP (3) JP2010511691A (de)
CN (2) CN103145812A (de)
AT (1) ATE542830T1 (de)
AU (1) AU2007330409B2 (de)
CA (1) CA2671553C (de)
DK (1) DK2099817T3 (de)
ES (2) ES2602782T3 (de)
HK (2) HK1117548A1 (de)
IL (1) IL199057A (de)
MX (1) MX2009005949A (de)
WO (1) WO2008068637A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9181543B2 (en) 2006-05-26 2015-11-10 Obodies Limited OB fold domains
CA2697032C (en) 2007-08-22 2021-09-14 The Regents Of The University Of California Activatable binding polypeptides and methods of identification and use thereof
CA2749339A1 (en) 2009-01-12 2010-07-15 Cytomx Therapeutics, Llc Modified antibody compositions, methods of making and using thereof
RU2011138951A (ru) 2009-02-23 2013-03-27 Сайтомкс Терапьютикс, Инк. Пропротеины и способы их применения
CN102597006A (zh) * 2009-09-16 2012-07-18 梅西大学 融合多肽以及其应用
EP2341079A1 (de) 2009-12-23 2011-07-06 Institut Pasteur Immunoglobulinbindende Proteine, die aus Sac7d abgeleitet wurden, und deren Verwendungen
EP2469278A1 (de) 2010-12-21 2012-06-27 Institut Pasteur Reagenzlose fluoreszente Biosensoren von Nanofitins, rationelle Designmethoden zur Erzeugung von reagenzlosen fluoreszenten Biosensoren, und ihre Einsatzmethoden
FR2974816A1 (fr) 2011-05-04 2012-11-09 Centre Nat Rech Scient Methode de generation de proteines
EP3489396B1 (de) 2012-12-27 2021-03-03 National Institute of Advanced Industrial Science and Technology Auf basis der backbone-struktur von mikroproteinen konstruierte molekülbibliothek
FR3004650B1 (fr) * 2013-04-22 2015-05-29 Affilogic Composition topique comprenant un variant d'une protéine sauvage à pli-OB, ainsi que son procédé de préparation
EP2955196A1 (de) 2014-06-10 2015-12-16 Effimune Gegen CD127 gerichtete Antikörper
CN106573961B (zh) 2014-06-20 2022-01-04 豪夫迈·罗氏有限公司 基于chagasin的支架组合物、方法和应用
FR3027521B1 (fr) * 2014-10-24 2016-12-16 Affilogic Compositions pour administration par voie orale
JP6952605B2 (ja) 2015-04-24 2021-10-20 ジェネンテック， インコーポレイテッド 多特異性抗原結合タンパク質
JP7053479B2 (ja) 2016-02-29 2022-04-12 オセ イムノセラピューティクス ＩＬ７受容体細胞外ドメインα鎖に対する非拮抗性抗体及び癌治療におけるそれらの使用
CN110198729A (zh) 2016-09-09 2019-09-03 豪夫迈·罗氏有限公司 卷曲蛋白的选择性肽抑制剂
US20190382483A1 (en) 2017-02-17 2019-12-19 Ose Immunotherapeutics NEW USES OF ANTI-SIRPg ANTIBODIES
EP3434692A1 (de) 2017-07-24 2019-01-30 Encefa Verbindungen mit spezifischer bindung an cd38 zur verwendung bei der behandlung von neurodegenerativen krankheiten
US11713356B2 (en) 2017-10-13 2023-08-01 Ose Immunotherapeutics Modified bifunctional anti-human signal regulatory protein alpha (SIRPa) antibody and method of use thereof for treating cancer
EP3483180A1 (de) 2017-11-14 2019-05-15 Affilogic Multispezifische moleküle
EP3723786A4 (de) * 2017-12-15 2021-09-08 Syngenta Participations Ag Nicht-antikörper-liganden zur detektion von zielproteinen
CN112105646A (zh) 2018-03-13 2020-12-18 Ose免疫疗法 抗人SIRPa v1抗体的用途和生产抗SIRPa v1抗体的方法
KR20210006359A (ko) 2018-04-03 2021-01-18 오제 이뮈노테라프틱스 항-케모카인 유사 수용체 1 항체 및 이의 치료적 용도
US20230242640A1 (en) 2018-08-22 2023-08-03 Ose Immunotherapeutics ANTI-SIRPg Compounds
EP3632924A1 (de) * 2018-10-07 2020-04-08 Affilogic Bindemittel zur hemmung der bildung von multimeren proteinen
KR20210107058A (ko) 2018-12-21 2021-08-31 오제 이뮈노테라프틱스 인간 pd-1에 대항하는 이작용성 분자
WO2020152290A1 (en) 2019-01-23 2020-07-30 Encefa Cd31 competitors and uses thereof
KR20220005568A (ko) 2019-05-09 2022-01-13 제넨테크, 인크. 항체의 제조 방법
US11597751B2 (en) 2019-05-16 2023-03-07 Massachusetts Institute Of Technology Glycan-binding proteins and related compositions and methods
CN114829388A (zh) * 2019-12-18 2022-07-29 伯拉考成像股份公司 抗her2多肽衍生物作为新的诊断分子探针
JP7511647B2 (ja) 2019-12-18 2024-07-05 ブラッコ・イメージング・ソシエタ・ペル・アチオニ 新規診断用分子プローブとしての抗ｈｅｒ２ポリペプチド誘導体
EP3878858A1 (de) 2020-03-11 2021-09-15 Affilogic Sac7d varianten und deren verwendung zur behandlung von krebs
GB202019817D0 (en) * 2020-12-15 2021-01-27 Univ Oxford Innovation Ltd Ligand-binding polypeptides and uses thereof
EP4043481A1 (de) * 2021-02-15 2022-08-17 Affilogic Verbindungen und verfahren zur verlängerung der halbwertszeit von biomolekülen
EP4059949A1 (de) 2021-03-18 2022-09-21 Affilogic Anti-faktor c3 sac7d-varianten und ihre medizinische verwendung zur behandlung komplementvermittelter störungen
JP2024513711A (ja) 2021-03-18 2024-03-27 アフィロジック 抗ｃ３因子ｓａｃ７ｄバリアントおよびその補体介在性障害を治療するための医学的使用
US20240263461A1 (en) * 2021-09-16 2024-08-08 Hitachi Global Life Solutions, Inc. Clean Room Facility
EP4190358A1 (de) 2021-12-05 2023-06-07 Affilogic Polypeptid als träger für die durchquerung von darmbarrieren
WO2023140360A1 (ja) * 2022-01-20 2023-07-27 京都府公立大学法人 抗体模倣分子

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696248B1 (en) 1995-08-18 2004-02-24 Morphosys Ag Protein/(poly)peptide libraries
AU4153497A (en) 1996-08-26 1998-03-19 Eli Lilly And Company Combinatorial process for preparing substituted thiophene libraries
EP1181358B1 (de) 1999-05-26 2010-11-17 Next Biomed Technologies NBT Oy VERFAHREN UND MATERIALIEN ZUR ERZEUGUNG VON SH3 DOMäNEN MIT ANGEPASSTEN BINDUNGSEIGENSCHAFTEN
AU5114000A (en) * 2000-06-14 2001-12-24 Imagene Co., Ltd. P43 anti-tumor therapeutic agent and three dimensional structure of its cytokinedomain
CA2418835A1 (en) * 2000-10-16 2002-04-25 Phylos, Inc. Protein scaffolds for antibody mimics and other binding proteins
US7560260B2 (en) * 2002-07-25 2009-07-14 Bio-Rad Laboratories, Inc. Compositions with polymerase activity
US7666645B2 (en) 2002-10-23 2010-02-23 Bio-Rad Laboratories, Inc. Sso7-polymerase conjugate proteins
JP4722035B2 (ja) * 2003-03-25 2011-07-13 アジレント・テクノロジーズ・インク Ｄｎａポリメラーゼ融合物およびその使用
US7462490B2 (en) 2003-10-31 2008-12-09 Chevron Oronite Company Llc Combinatorial lubricating oil composition libraries
JP2007537716A (ja) * 2003-12-16 2007-12-27 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼイション サイトカイン結合ドメイン
GB0416651D0 (en) * 2004-07-26 2004-08-25 Proteo Target Aps Polypeptide
US20090054252A1 (en) * 2005-01-03 2009-02-26 Martin Lanzendoerfer Hemopexin-Like Structure as New Polypeptide-Scaffold
GB0500099D0 (en) * 2005-01-05 2005-02-09 Cambridge Antibody Tech Methods and means relating to protein variants
US9181543B2 (en) * 2006-05-26 2015-11-10 Obodies Limited OB fold domains
EP1892248A1 (de) 2006-08-21 2008-02-27 Eidgenössische Technische Hochschule Zürich Bindeproteine mit spezifischer und hoher Affinität enthaltend modifizierte SH3-Domänen von FYN-Kinasen

Also Published As

Publication number Publication date
ES2602782T3 (es) 2017-02-22
US9422548B2 (en) 2016-08-23
EP2099817A2 (de) 2009-09-16
JP2018035139A (ja) 2018-03-08
HK1141304A1 (en) 2010-11-05
EP2099817B1 (de) 2015-02-11
EP2570424B1 (de) 2016-09-28
EP1930342B1 (de) 2012-01-25
WO2008068637A2 (en) 2008-06-12
AU2007330409A1 (en) 2008-06-12
US20100145008A1 (en) 2010-06-10
ES2536509T3 (es) 2015-05-26
IL199057A (en) 2016-02-29
US20170166887A1 (en) 2017-06-15
DK2099817T3 (en) 2015-05-18
US20160010083A1 (en) 2016-01-14
CN103145812A (zh) 2013-06-12
CN101652386A (zh) 2010-02-17
JP6684761B2 (ja) 2020-04-22
EP1930342A1 (de) 2008-06-11
CA2671553A1 (en) 2008-06-12
JP2014169304A (ja) 2014-09-18
CA2671553C (en) 2017-09-05
JP2010511691A (ja) 2010-04-15
US10584330B2 (en) 2020-03-10
WO2008068637A3 (en) 2008-10-30
JP6253496B2 (ja) 2017-12-27
ATE542830T1 (de) 2012-02-15
MX2009005949A (es) 2009-06-30
AU2007330409B2 (en) 2013-04-18
EP2570424A1 (de) 2013-03-20
US11434585B2 (en) 2022-09-06
CN101652386B (zh) 2013-03-20
US20200181601A1 (en) 2020-06-11

Similar Documents

Publication Publication Date Title
HK1141304A1 (en) Ob-fold used as scaffold for engineering new specific binders ob-fold
EP4306653A3 (de) Zielnummer für optimierte multiplex-fehlanpassungsverstärkung (moma)
HK1256740A1 (zh) 白介素-13結合蛋白
EP2193145A4 (de) Zusammensetzungen und verfahren mit bindungsproteinen für adalimumab
WO2008133722A3 (en) Anti human sclerostin antibodies
MX2008011874A (es) Composiciones estabilizadas de polipeptidos.
MX2009009200A (es) Tratamiento de enfermedades caracterizadas por la inflamacion.
EP3769775A3 (de) Zusammensetzungen zur vernetzung von dna-bindungsdomänen und -spaltungsdomänen
NZ597756A (en) Method for purifying recombinant adamts13 and other proteins and compositions thereof
IL187168A (en) Proteins or polypeptides containing two identical nanobedis against Factor von Willebrand, methods for their preparation, medicinal preparations containing them and their use
WO2007117564A3 (en) Clay-binding peptides and methods of use
IL198872A0 (en) Igf-1r binding proteins and compositions containing the same
WO2006017538A3 (en) Hk1-binding proteins
IL197061A (en) Compounds that inhibit the interaction of bcl proteins with binding partners, their medicinal products and their use
PT1991680E (pt) Sistema para a expressão de componentes ortogonais de tradução em células hospedeiras eubacterianas
EA200801531A1 (ru) Способы регулирования содержания маннозы в рекомбинантных белках
WO2009111450A3 (en) Metalloproteinase 9 binding proteins
WO2009111508A3 (en) Metalloproteinase 9 and metalloproteinase 2 binding proteins
TW200833318A (en) An extract
WO2007120638A3 (en) Methods and compositions for modulating glycosylation
WO2007022287A3 (en) Modified vegf and pdgf with improved angiogenic properties
MX2008000230A (es) Proteinas de enlace il-6.
EP3487998A4 (de) Zusammensetzungen und verfahren zur identifizierung von rna-bindenden polypeptidzielen
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
MX341064B (es) Variantes de la familia il-1.